In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Impact BioMedical Inc (AMEX: IBO) was $0.43 for the day, up 3.97% from the previous closing price of $0.41. In other words, the price has increased by $3.97 from its previous closing price. On the day, 0.32 million shares were traded.
Ratios:
Our analysis of IBO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.25 and its Current Ratio is at 0.25. In the meantime, Its Debt-to-Equity ratio is 2.08 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 04 ’25 when DSS, INC. sold 890,800 shares for $0.95 per share. The transaction valued at 845,013 led to the insider holds 161,100 shares of the business.
Chan Heng Fai Ambrose sold 351,555 shares of IBO for $174,020 on Apr 03 ’25. The Director now owns 0 shares after completing the transaction at $0.49 per share. On Apr 02 ’25, another insider, Chan Heng Fai Ambrose, who serves as the Director of the company, sold 884,776 shares for $0.60 each. As a result, the insider received 533,636 and left with 351,555 shares of the company.
Stock Price History:
Over the past 52 weeks, IBO has reached a high of $6.17, while it has fallen to a 52-week low of $0.37. The 50-Day Moving Average of the stock is -63.54%, while the 200-Day Moving Average is calculated to be -75.66%.
Shares Statistics:
A total of 11.50M shares are outstanding, with a floating share count of 10.07M. Insiders hold about 12.50% of the company’s shares, while institutions hold 0.66% stake in the company.
